# Psychiatry (mood disorders) Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Paul Robeson (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML048-SYN-TD
- Date: 1957-03-12
- Fictional facility: St. Posthumous Health Center
- Fictional author: Esther Lindqvist-Adebayo, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Requested by: Theodore Bankole-Ashworth, MD

## Reason for consultation

Probable severe major depression in a 58-year-old singer and actor under sustained political persecution, with passive thoughts of death. Please confirm the diagnosis with a structured interview, screen for bipolar disorder, judge suicide risk and the level of care, and advise on treatment, including when ECT or other treatments would be indicated. **S**

## History

Mr. Robeson, a 58-year-old singer, actor and civil rights activist trained in law, is seen at the request of Dr. Bankole-Ashworth three days after his first visit. He describes about three months of low mood, exhaustion, early waking, poor appetite and loss of interest, with withdrawal from friends and from singing. He had a first depression about two years ago, after prostate surgery, that lifted slowly over some months without treatment. Before it he had some weeks of intense, absorbed work, sleeping his usual hours, without elation, irritability, racing thoughts, spending or other risky behavior. He has thoughts on some days that he would be better off dead, without intent or plan, and has never attempted suicide. He has lost most of his work and income, cannot travel abroad, and believes his telephone is listened to. He asked who would see this note and was told. **S**

## Examination

| System | Finding |
|---|---|
| General | Tall, well groomed and courteous; blood pressure 126/78, pulse 74 |
| Psychiatric | Psychomotor slowing; quiet speech; mood 'worn through'; constricted affect; logical, goal-directed thought; no delusions or hallucinations; passive thoughts of death without intent or plan; insight and judgment good |
| Neurological | No tremor or focal signs |

BP 126/78 mmHg; pulse 74 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 98.8 kg; BMI 27.4 kg/m². All vital signs are synthetic.

## Data reviewed

Dr. Bankole-Ashworth's intake note, safety assessment and results: PHQ-9 22 (item 9 scored 1), GAD-7 12, MoCA 28; blood count, sodium 140, potassium 4.2, creatinine 1.05 mg/dL, glucose 92, calcium 9.4, TSH 1.8, vitamin B12 420, folate 9.5, morning testosterone 420 ng/dL and A1c 5.6%, all normal; HIV and syphilis tests negative. Structured diagnostic interview today (mood, psychosis, anxiety, trauma and substance modules) and the Mood Disorder Questionnaire (5 of 13 items, not in one period). 

## Assessment

1. **Major depressive disorder, recurrent, severe, without psychotic features** (F33.2). He meets criteria for a second major depressive episode, severe, without psychotic features. The MDQ is negative and the interview finds no past hypomanic or manic episode: the earlier period of intense work did not include reduced need for sleep, elation or irritability, so bipolar disorder is not diagnosed, but he should be watched for activation once an antidepressant starts. The tests exclude the common medical causes. Severe depression with a sustained stressor and passive thoughts of death in an older man needs close follow-up, but he has no intent or plan, good supports and a safety plan, so outpatient care is appropriate. **S**
2. **Persecution and surveillance** (Z60.5). His concern about being watched is plausible, specific and consistent with his circumstances; it is not a delusion, and labelling it as paranoia would be a diagnostic error of the kind documented more often in Black patients. Depression, rather than psychosis, explains his presentation, and the persecution is a real stressor that therapy should address directly. **S**

## Recommendations

1. Outpatient care with the written safety plan, locked medicines, no firearm, the 988 Suicide & Crisis Lifeline, and a C-SSRS screen at every visit; admission if thoughts become active, with intent or a plan.
2. Behavioral activation weekly for about sixteen sessions with a psychologist he chooses, then CBT if needed.
3. Sertraline 50 mg each morning, 100 mg at two weeks, then up to 200 mg by eight weeks as tolerated; sodium at about six weeks; PHQ-9 at every visit, with response as a 50 percent fall and remission as a score below 5.
4. If the PHQ-9 falls by less than a quarter after an adequate trial (at least four to eight weeks at an adequate dose), switch to an SNRI such as venlafaxine extended-release up to 225 mg, with blood pressure checks and 30-day supplies.
5. If a second adequate trial brings only a partial response, treat it as treatment-resistant depression: augmentation with aripiprazole (with metabolic and movement monitoring) or lithium, or ECT, rTMS or esketamine.
6. ECT is not indicated now; it is indicated first for psychotic depression, refusal of food or drink, or acute suicidal risk, and is a choice for treatment-resistant depression. If chosen, it should be given with his own informed consent, under general anesthesia with a muscle relaxant, usually right unilateral with an ultrabrief pulse, two or three times a week in a defined course, with the MoCA repeated before and during the course, and with his right to stop at any time.
7. Repeat the MDQ and review the diagnosis if he develops elation, reduced need for sleep or racing thoughts.
8. Explain how his record is protected and keep the psychiatric notes to what care requires.

## Strengths and supports

- Supports he names: his music and the spirituals he grew up with, his work for civil rights, and old friends from the stage and the movement **S**

## Communication

Discussed with Dr. Bankole-Ashworth the same morning; he will prescribe and coordinate the psychologist and social worker, and I am available by phone for each medicine change. Mr. Robeson agreed to the plan and asked that no treatment, especially ECT, be given without his own agreement; he was assured that it would not be. **S**

## Follow-up

Telephone review with Dr. Bankole-Ashworth at each medicine change, and a further consultation if two antidepressant trials fail or if risk rises. **S**

## Guideline basis

- APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019), American Psychological Association
- VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022), U.S. Department of Veterans Affairs and Department of Defense
- The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. A Task Force Report of the American Psychiatric Association, 2nd edition (record of the American Journal of Psychiatry review, 2002) (2001), American Psychiatric Association
- The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. A Task Force Report of the American Psychiatric Association, 3rd edition (Library of Congress catalog record, LCCN 2024014438) (2024), American Psychiatric Association Publishing
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), U.S. Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
- Williams DR, et al. Prevalence and distribution of major depressive disorder in African Americans, Caribbean blacks, and non-Hispanic whites: results from the National Survey of American Life. Arch Gen Psychiatry 2007;64(3):305-315 (2007), Archives of General Psychiatry (PubMed 17339519)
- Racial disparities in psychotic disorder diagnosis: A review of empirical literature (2014), World Journal of Psychiatry (PubMed 25540728)
